Sign in
4/A

Changes in Ownership

Cardiff Oncology, Inc. Filed Acc 0000899243-18-000527

Chief Scientific Officer gave up 9,558 shares (to pay taxes)

  • Chief Scientific Officer acquired 18,750 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Erlander Mark · Chief Scientific Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Owned after D/I
2018-01-02 Exercise or conversion : show line 1 in the form +18,750 66,855 D
2018-01-02 Shares withheld for taxes : show line 2 in the form −9,558 57,297 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2018-01-02 Exercise or conversion : show line 3 in the form Restricted Stock Units −18,750 146,250 D
Loading xslF345X03/doc4a.xml…